Published: Wed, 16 May 2018
Ireland South MEP Sean Kelly will host the launch event of (bio)Pharma Europe in Brussels next Tuesday, 22nd May, to encourage action towards timely and reliable access to safe, cost-effective medicines across Europe.
“Europe is the second largest global market for (bio)Pharmaceutical products. In 2016 alone, the sector directly reinvested €35 billion into research and development activities in Europe. This affects the day-to-day lives of European citizens, improves quality of life and lengthens life expectancies,” said the leader of the Fine Gael delegation in the European Parliament.
This launch will prioritise investment in the manufacture of innovative medicines:
“Great steps have been made across Europe regarding investment in the discovery of innovative medicines. However a lot of work remains to be done in their development and manufacturing, as well as the creation of a supportive regulatory environment to facilitate innovation in this area,” Mr. Kelly added, speaking in Brussels this week.
Representing EPP – the biggest political group in the European Parliament – Mr. Kelly will host (bio)Pharma Europe’s briefing to facilitate exchange on the important work of this growing, inclusive partnership which runs across 8 EU Member States at present.
“It is imperative that we make strides to facilitate the end-to-end pharmaceutical product life cycle. Otherwise, Europe will be left behind the other ‘Pharmerging’ economies such as China, Brazil and India,” highlighted the Ireland-South MEP.
Experts in the field will join policymakers and other stakeholders next week to advocate for progressive regulatory change in this area, and to set out research agendas and roadmaps to ensure that lasting changes can be made.